🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsGlucagon receptor agonism and hepatic lipid oxidation — 6 month update Page 3

Glucagon receptor agonism and hepatic lipid oxidation — 6 month update

JennaRN Fri, Aug 30, 2024 at 5:22 AM 12 replies 2,000 viewsPage 3 of 3
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Sep 2, 2024 at 5:16 AM#11
Dr.EM_Chicago said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

12 10JakeSmashed95, NauseaFreeNow, SteveThurs and 9 others
Reply Quote Save Share Report
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Sep 3, 2024 at 12:40 PM#12
ingrid_STO said:
Agreed, and the adaptation point cuts both ways: tachyphylaxis to gastric emptying is why tolerability improves, and it is also why people who were…

Saving this. It is the first explanation that did not require me to already understand it. Printing the relevant bit and taking it with me.

13 11TrialTracker_MD, JennaRN, LabKate and 10 others
Reply Quote Save Share Report
rick_sfbay
Member
289
1,234
Jan 2025
San Francisco, CA
Sep 4, 2024 at 8:03 PM#13
Dr.EM_Chicago said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

Worth separating that from the pharmacology, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

14 12james_edin, FranDenver, Dr.BariatricHTX and 11 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Sep 6, 2024 at 3:25 AM#14

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

Last edited: Sep 6, 2024 at 9:25 AM
15 13SaraMom3, Dr.MetabolicMD, RetaRick_CA and 12 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Sep 7, 2024 at 10:47 AM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.

16 14PurityPaulOR, MaxMetOK, MounjBrad and 13 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register